{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:24:15Z","timestamp":1788823455723,"version":"build-2803163510"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230130","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T13:52:27Z","timestamp":1583848347000},"page":"e0230130","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-0999","authenticated-orcid":true,"given":"Josep","family":"Darb\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Mars\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"issue":"4","key":"pone.0230130.ref001","first-page":"249","article-title":"Parathyroid disorders","volume":"88","author":"TC Michels","year":"2013","journal-title":"Am Fam Physician"},{"key":"pone.0230130.ref002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000486003","article-title":"Metabolic Syndrome in Parathyroid Diseases","volume":"49","author":"S Corbetta","year":"2018","journal-title":"Front Horm Res"},{"key":"pone.0230130.ref003","unstructured":"National Institute for Health and Care Excellence (NICE). Hyperparathyroidism (primary): diagnosis, assessment and initial management. NICE Guideline, No. 132. London: National Institute for Health and Care Excellence (UK); 2019."},{"issue":"4","key":"pone.0230130.ref004","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","article-title":"Epidemiology of primary hyperparathyroidism in Tayside, Scotland","volume":"71","author":"N Yu","year":"2009","journal-title":"UK. Clin Endocrinol (Oxf)"},{"issue":"3","key":"pone.0230130.ref005","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"MW Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"pone.0230130.ref006","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease","volume":"21","author":"RA Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"1","key":"pone.0230130.ref007","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2012.11.009","article-title":"Epidemiology of primary hyperparathyroidism","volume":"16","author":"BL Clarke","year":"2013","journal-title":"J Clin Densitom"},{"issue":"7","key":"pone.0230130.ref008","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00198-014-2689-2","article-title":"Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism","volume":"25","author":"E Koumakis","year":"2014","journal-title":"Osteoporos Int"},{"issue":"10116","key":"pone.0230130.ref009","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"JP Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"pone.0230130.ref010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11154-017-9421-4","article-title":"Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies","volume":"18","author":"MR Portillo","year":"2017","journal-title":"Rev Endocr Metab DisordMar"},{"key":"pone.0230130.ref011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000491041","article-title":"Secondary and Tertiary Hyperparathyroidism","volume":"51","author":"P Messa","year":"2019","journal-title":"Front Horm Res"},{"issue":"9\u201310","key":"pone.0230130.ref012","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00508-016-1153-z","article-title":"Management of secondary hyperparathyroidism: practice patterns and outcomes of cinacalcet treatment with or without active vitamin D in Austria and Switzerland\u2014the observational TRANSIT Study","volume":"129","author":"W Pronai","year":"2017","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"pone.0230130.ref013","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults","volume":"173","author":"J Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"pone.0230130.ref014","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and Diagnosis of Hypoparathyroidism","volume":"101","author":"BL Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0230130.ref015","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"M Mannstadt","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"pone.0230130.ref016","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ecl.2018.07.004","article-title":"Epidemiology and Complications of Hypoparathyroidism","volume":"47","author":"BL Clarke","year":"2018","journal-title":"Endocrinol Metab Clin North AmDec"},{"issue":"6","key":"pone.0230130.ref017","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of Hypoparathyroidism: Summary Statement and Guidelines","volume":"101","author":"ML Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0230130.ref018","unstructured":"Law 14\/2007, 3 July, on biomedical research (BOE, 4 July 2007). Rev Derecho Genoma Hum. 2007 Jan-Jun; (26):283\u2013325."},{"key":"pone.0230130.ref019","article-title":"Epidemiology of primary hyperparathyroidism in Santander, Spain","volume":"56","author":"L Ramos","year":"2018","journal-title":"Endocrine Abstracts"},{"key":"pone.0230130.ref020","unstructured":"Heatlh data. Unit of Health Care Information and Statistics of the Spanish Ministry of Health. Available at https:\/\/www.mscbs.gob.es\/estadEstudios\/sanidadDatos\/home.htm Accessed 5 Dec 2019."},{"issue":"2","key":"pone.0230130.ref021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop","volume":"94","author":"JP Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"pone.0230130.ref022","first-page":"957","article-title":"Results from a national survey on the management of primary hyperparathyroidism","volume":"35","author":"M Mu\u00f1oz Torres","year":"2012","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"pone.0230130.ref023","first-page":"456.e1","article-title":"Normocalcemic primary hyperparathyroidism: Recommendations for management and follow-up","volume":"60","author":"Grupo de Trabajo de Metabolismo Mineral y \u00d3seo de la Sociedad Espa\u00f1ola de Endocrinolog\u00eda y Nutrici\u00f3n","year":"2013","journal-title":"Endocrinol Nutr"},{"issue":"10","key":"pone.0230130.ref024","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"JP Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"pone.0230130.ref025","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-19-0316","article-title":"Management of endocrine disease: Unmet therapeutic, educational and scientific needs in parathyroid disorders","volume":"181","author":"J Bollerslev","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"pone.0230130.ref026","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000658-200005000-00014","article-title":"Effect of minimally invasive radioguided parathyroidectomy on efficacy, length of stay, and costs in the management of primary hyperparathyroidism","volume":"231","author":"RE Goldstein","year":"2000","journal-title":"Ann Surg"},{"issue":"2","key":"pone.0230130.ref027","first-page":"e24","article-title":"Costs of Treatment and Clinical Events for Secondary Hyperparathyroidism","volume":"5","author":"A Lee","year":"2013","journal-title":"Am J Pharm Benefits"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T13:52:51Z","timestamp":1583848371000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230130"}},"subtitle":[],"editor":[{"given":"Ana Paula","family":"Arez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230130","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]}}}